  |
2GNS |
Design of specific peptide inhibitors of phospholipase A2: Crystal structure of the complex formed between a group II phospholipase A2 and a designed pentapeptide Ala- Leu- Val- Tyr- Lys at 2.3 A resolution |
P |
A |
Phospholipase A2. PLA2 |
 |
  |
1TJK |
Crystal structure of the complex formed between group II phospholipase A2 with a designed pentapeptide, Phe- Leu- Ser- Thr- Lys at 1.2 A resolution |
I |
A |
Phospholipase A2. PLA2 |
|
  |
1TDV |
Non-specific binding to phospholipase A2:Crystal structure of the complex of PLA2 with a designed peptide Tyr-Trp-Ala-Ala-Ala-Ala at 1.7A resolution |
B |
A |
Phospholipase A2. PLA2 |
|
  |
1TG4 |
Design of specific inhibitors of groupII phospholipase A2(PLA2): Crystal structure of the complex formed between russells viper PLA2 and designed peptide Phe-Leu-Ala-Tyr-Lys at 1.7A resolution |
I |
A |
Phospholipase A2. PLA2 |
|
  |
1SKG |
Structure-based rational drug design: Crystal structure of the complex formed between Phospholipase A2 and a pentapeptide Val-Ala-Phe-Arg-Ser |
B |
A |
Phospholipase A2. PLA2 |
|
  |
1MF4 |
Structure-based design of potent and selective inhibitors of phospholipase A2: Crystal structure of the complex formed between phosholipase A2 from Naja Naja sagittifera and a designed peptide inhibitor at 1.9 A resolution |
B |
A |
Phospholipase A2. PLA2 |
|
  |
1JQ8 |
Design of specific inhibitors of phospholipase A2: Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Leu-Ala-Ile-Tyr-Ser at 2.0 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
  |
1JQ9 |
Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Phe-Leu-Ser-Tyr-Lys at 1.8 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
